A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis
NCT01782339
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Germ Cell Tumour
Interventions
DRUG:
Combination Chemotherapy
Sponsor
Barts & The London NHS Trust